Dianthus Therapeutics, Inc. /DE/ (DNTH) Deferred Tax Assets, Gross USD 2017 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Deferred Tax Assets, Gross history and growth rate from 2017 to 2023.
  • Dianthus Therapeutics, Inc. /DE/ Deferred Tax Assets, Gross for the quarter ending December 31, 2023 was $137 M, a 1063% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $137 M +$125 M +1063% Dec 31, 2023 10-K 2024-03-21
Q4 2022 $11.8 M +$6.56 M +126% Dec 31, 2022 10-K 2024-03-21
Q4 2021 $5.2 M -$69.8 M -93.1% Dec 31, 2021 8-K 2023-12-21
Q4 2020 $75 M +$21.2 M +39.3% Dec 31, 2020 10-K 2022-03-08
Q4 2019 $53.8 M +$24.2 M +81.8% Dec 31, 2019 10-K 2021-03-03
Q4 2018 $29.6 M +$17.1 M +137% Dec 31, 2018 10-K 2020-03-03
Q4 2017 $12.5 M Dec 31, 2017 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.